Detalhe da pesquisa
1.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog;
162: 105341, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34883228
2.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog;
151: 104745, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33485994
3.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol;
210(2-3): 133-147, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33870453
4.
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitology;
148(13): 1706-1714, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35060464
5.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Cell Immunol;
356: 104194, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32827943
6.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog;
147: 104283, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32485231
7.
An immunoproteomics approach to identify Leishmania infantum proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection.
Parasitology;
147(9): 932-939, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32308186
8.
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Exp Parasitol;
216: 107941, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32622940
9.
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Microb Pathog;
137: 103783, 2019 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31600536
10.
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
Parasitology;
146(3): 322-332, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30198459
11.
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Cell Immunol;
323: 59-69, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29128045
12.
Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
Int J Mol Sci;
19(1)2018 Jan 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29301342
13.
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans.
Cell Immunol;
318: 42-48, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28602279
14.
Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis.
Microb Pathog;
110: 14-22, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28629727
15.
Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins.
Vet Parasitol;
296: 109513, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34225189
16.
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study.
Acta Trop;
224: 106126, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34537185
17.
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
Mol Immunol;
124: 161-171, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32585510
18.
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
Vaccines (Basel);
8(2)2020 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32526867
19.
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
Immunol Lett;
220: 11-20, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31981576
20.
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
NPJ Vaccines;
5: 75, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32821440